Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
357 |
1672 |
3.721e-44 |
1.731e-40 |
2 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
214 |
771 |
7.953e-44 |
1.85e-40 |
3 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
365 |
1848 |
2.868e-37 |
3.507e-34 |
4 |
REGULATION OF CELL DIFFERENTIATION |
314 |
1492 |
3.015e-37 |
3.507e-34 |
5 |
BIOLOGICAL ADHESION |
244 |
1032 |
4.144e-37 |
3.857e-34 |
6 |
TISSUE DEVELOPMENT |
316 |
1518 |
1.597e-36 |
1.238e-33 |
7 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
199 |
788 |
2.235e-34 |
1.3e-31 |
8 |
CIRCULATORY SYSTEM DEVELOPMENT |
199 |
788 |
2.235e-34 |
1.3e-31 |
9 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
286 |
1395 |
1.022e-31 |
5.286e-29 |
10 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
230 |
1021 |
1.429e-31 |
6.65e-29 |
11 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
356 |
1929 |
4.569e-30 |
1.776e-27 |
12 |
VASCULATURE DEVELOPMENT |
136 |
469 |
4.579e-30 |
1.776e-27 |
13 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
244 |
1142 |
9.085e-30 |
3.252e-27 |
14 |
CELL DEVELOPMENT |
284 |
1426 |
2.876e-29 |
8.921e-27 |
15 |
REGULATION OF CELL PROLIFERATION |
294 |
1496 |
2.689e-29 |
8.921e-27 |
16 |
LOCOMOTION |
238 |
1114 |
5.043e-29 |
1.467e-26 |
17 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
314 |
1656 |
1.815e-28 |
4.968e-26 |
18 |
BLOOD VESSEL MORPHOGENESIS |
113 |
364 |
5.883e-28 |
1.483e-25 |
19 |
NEUROGENESIS |
277 |
1402 |
6.054e-28 |
1.483e-25 |
20 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
307 |
1618 |
7.34e-28 |
1.708e-25 |
21 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
258 |
1275 |
1.252e-27 |
2.774e-25 |
22 |
RESPONSE TO ENDOGENOUS STIMULUS |
280 |
1450 |
1.365e-26 |
2.886e-24 |
23 |
POSITIVE REGULATION OF CELL COMMUNICATION |
291 |
1532 |
1.915e-26 |
3.565e-24 |
24 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
220 |
1036 |
1.899e-26 |
3.565e-24 |
25 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
220 |
1036 |
1.899e-26 |
3.565e-24 |
26 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
212 |
1008 |
6.365e-25 |
1.139e-22 |
27 |
POSITIVE REGULATION OF LOCOMOTION |
118 |
420 |
6.864e-25 |
1.168e-22 |
28 |
REGULATION OF CELL DEVELOPMENT |
186 |
836 |
7.026e-25 |
1.168e-22 |
29 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
310 |
1710 |
1.133e-24 |
1.818e-22 |
30 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
178 |
799 |
6.712e-24 |
1.041e-21 |
31 |
REGULATION OF CELL ADHESION |
151 |
629 |
9.079e-24 |
1.363e-21 |
32 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
277 |
1492 |
1.408e-23 |
2.047e-21 |
33 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
204 |
983 |
3.029e-23 |
4.27e-21 |
34 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
180 |
823 |
3.321e-23 |
4.544e-21 |
35 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
151 |
643 |
9.499e-23 |
1.263e-20 |
36 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
259 |
1381 |
1.132e-22 |
1.463e-20 |
37 |
CELL CELL ADHESION |
145 |
608 |
1.459e-22 |
1.835e-20 |
38 |
POSITIVE REGULATION OF GENE EXPRESSION |
306 |
1733 |
1.865e-22 |
2.284e-20 |
39 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
129 |
513 |
2.526e-22 |
3.014e-20 |
40 |
CELL MOTILITY |
179 |
835 |
4.601e-22 |
5.221e-20 |
41 |
LOCALIZATION OF CELL |
179 |
835 |
4.601e-22 |
5.221e-20 |
42 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
222 |
1135 |
8.633e-22 |
9.564e-20 |
43 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
91 |
304 |
1.627e-21 |
1.761e-19 |
44 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
229 |
1192 |
2.001e-21 |
2.116e-19 |
45 |
INTRACELLULAR SIGNAL TRANSDUCTION |
281 |
1572 |
2.189e-21 |
2.264e-19 |
46 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
252 |
1360 |
2.569e-21 |
2.599e-19 |
47 |
ORGAN MORPHOGENESIS |
177 |
841 |
6.402e-21 |
6.338e-19 |
48 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
171 |
801 |
6.564e-21 |
6.363e-19 |
49 |
ANGIOGENESIS |
87 |
293 |
2.277e-20 |
2.162e-18 |
50 |
REGULATION OF NEURON DIFFERENTIATION |
131 |
554 |
3.91e-20 |
3.639e-18 |
51 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
180 |
876 |
4.322e-20 |
3.943e-18 |
52 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
161 |
750 |
5.57e-20 |
4.984e-18 |
53 |
MUSCLE STRUCTURE DEVELOPMENT |
110 |
432 |
1.222e-19 |
1.073e-17 |
54 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
190 |
957 |
1.899e-19 |
1.636e-17 |
55 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
303 |
1791 |
2.43e-19 |
2.056e-17 |
56 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
304 |
1805 |
4.119e-19 |
3.422e-17 |
57 |
RESPONSE TO EXTERNAL STIMULUS |
306 |
1821 |
4.324e-19 |
3.53e-17 |
58 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
183 |
917 |
5.312e-19 |
4.261e-17 |
59 |
HEART DEVELOPMENT |
114 |
466 |
7.363e-19 |
5.807e-17 |
60 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
300 |
1784 |
9.3e-19 |
7.212e-17 |
61 |
POSITIVE REGULATION OF CELL PROLIFERATION |
167 |
814 |
1.263e-18 |
9.636e-17 |
62 |
EPITHELIUM DEVELOPMENT |
184 |
945 |
6.138e-18 |
4.607e-16 |
63 |
BEHAVIOR |
120 |
516 |
6.249e-18 |
4.615e-16 |
64 |
SKELETAL SYSTEM DEVELOPMENT |
110 |
455 |
7.814e-18 |
5.681e-16 |
65 |
REGULATION OF MAPK CASCADE |
140 |
660 |
4.931e-17 |
3.53e-15 |
66 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
259 |
1518 |
5.232e-17 |
3.689e-15 |
67 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
189 |
1004 |
8.005e-17 |
5.559e-15 |
68 |
REGULATION OF CELL DEATH |
252 |
1472 |
9.694e-17 |
6.633e-15 |
69 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
110 |
472 |
1.327e-16 |
8.946e-15 |
70 |
CONNECTIVE TISSUE DEVELOPMENT |
62 |
194 |
1.359e-16 |
9.035e-15 |
71 |
CELLULAR COMPONENT MORPHOGENESIS |
173 |
900 |
2.346e-16 |
1.537e-14 |
72 |
NEURON DIFFERENTIATION |
169 |
874 |
3.01e-16 |
1.945e-14 |
73 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
142 |
689 |
3.76e-16 |
2.397e-14 |
74 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
130 |
609 |
4.038e-16 |
2.539e-14 |
75 |
REGULATION OF CELL PROJECTION ORGANIZATION |
122 |
558 |
5.136e-16 |
3.187e-14 |
76 |
REGULATION OF SYSTEM PROCESS |
114 |
507 |
5.857e-16 |
3.586e-14 |
77 |
REGULATION OF TRANSPORT |
292 |
1804 |
6.017e-16 |
3.636e-14 |
78 |
RESPONSE TO LIPID |
170 |
888 |
6.46e-16 |
3.854e-14 |
79 |
CELLULAR RESPONSE TO LIPID |
106 |
457 |
6.803e-16 |
4.007e-14 |
80 |
TAXIS |
107 |
464 |
7.577e-16 |
4.407e-14 |
81 |
RESPONSE TO HORMONE |
170 |
893 |
1.11e-15 |
6.378e-14 |
82 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
97 |
408 |
2.255e-15 |
1.279e-13 |
83 |
RESPONSE TO WOUNDING |
121 |
563 |
2.6e-15 |
1.457e-13 |
84 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
76 |
285 |
4.051e-15 |
2.244e-13 |
85 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
117 |
541 |
4.765e-15 |
2.578e-13 |
86 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
117 |
541 |
4.765e-15 |
2.578e-13 |
87 |
SINGLE ORGANISM CELL ADHESION |
104 |
459 |
6.733e-15 |
3.601e-13 |
88 |
SINGLE ORGANISM BEHAVIOR |
92 |
384 |
7.283e-15 |
3.851e-13 |
89 |
TISSUE MORPHOGENESIS |
115 |
533 |
9.774e-15 |
5.11e-13 |
90 |
RESPONSE TO GROWTH FACTOR |
106 |
475 |
1.081e-14 |
5.586e-13 |
91 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
100 |
437 |
1.154e-14 |
5.901e-13 |
92 |
RESPONSE TO NITROGEN COMPOUND |
162 |
859 |
1.288e-14 |
6.515e-13 |
93 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
104 |
465 |
1.661e-14 |
8.31e-13 |
94 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
168 |
905 |
1.745e-14 |
8.639e-13 |
95 |
MUSCLE TISSUE DEVELOPMENT |
73 |
275 |
1.825e-14 |
8.939e-13 |
96 |
UROGENITAL SYSTEM DEVELOPMENT |
77 |
299 |
2.05e-14 |
9.934e-13 |
97 |
TUBE DEVELOPMENT |
117 |
552 |
2.141e-14 |
1.016e-12 |
98 |
REGULATION OF CELL MORPHOGENESIS |
117 |
552 |
2.141e-14 |
1.016e-12 |
99 |
RESPONSE TO ABIOTIC STIMULUS |
184 |
1024 |
2.226e-14 |
1.046e-12 |
100 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
78 |
306 |
2.516e-14 |
1.171e-12 |
101 |
POSITIVE REGULATION OF MAPK CASCADE |
104 |
470 |
3.465e-14 |
1.596e-12 |
102 |
POSITIVE REGULATION OF CELL DEATH |
124 |
605 |
4.606e-14 |
2.101e-12 |
103 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
109 |
505 |
4.824e-14 |
2.179e-12 |
104 |
NEURON PROJECTION MORPHOGENESIS |
93 |
402 |
4.988e-14 |
2.232e-12 |
105 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
96 |
422 |
5.802e-14 |
2.571e-12 |
106 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
87 |
368 |
8.947e-14 |
3.927e-12 |
107 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
161 |
872 |
1.025e-13 |
4.459e-12 |
108 |
REGULATION OF ION TRANSPORT |
121 |
592 |
1.157e-13 |
4.986e-12 |
109 |
NEURON PROJECTION DEVELOPMENT |
114 |
545 |
1.199e-13 |
5.117e-12 |
110 |
NEGATIVE REGULATION OF GENE EXPRESSION |
243 |
1493 |
1.337e-13 |
5.656e-12 |
111 |
REGULATION OF VASCULATURE DEVELOPMENT |
64 |
233 |
1.37e-13 |
5.743e-12 |
112 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
49 |
153 |
1.892e-13 |
7.862e-12 |
113 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
58 |
204 |
3.869e-13 |
1.593e-11 |
114 |
NEURON DEVELOPMENT |
133 |
687 |
4.759e-13 |
1.943e-11 |
115 |
REGULATION OF OSSIFICATION |
53 |
178 |
5.335e-13 |
2.159e-11 |
116 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
113 |
552 |
6.909e-13 |
2.771e-11 |
117 |
MESENCHYME DEVELOPMENT |
55 |
190 |
7.006e-13 |
2.786e-11 |
118 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
80 |
337 |
7.106e-13 |
2.802e-11 |
119 |
REGULATION OF KINASE ACTIVITY |
145 |
776 |
7.179e-13 |
2.807e-11 |
120 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
243 |
1517 |
7.753e-13 |
3.006e-11 |
121 |
CELL ACTIVATION |
115 |
568 |
9.26e-13 |
3.561e-11 |
122 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
195 |
1152 |
1.25e-12 |
4.769e-11 |
123 |
CIRCULATORY SYSTEM PROCESS |
84 |
366 |
1.333e-12 |
5.042e-11 |
124 |
WOUND HEALING |
100 |
470 |
1.365e-12 |
5.122e-11 |
125 |
REGULATION OF EPITHELIAL CELL MIGRATION |
50 |
166 |
1.49e-12 |
5.542e-11 |
126 |
PROTEIN PHOSPHORYLATION |
167 |
944 |
1.501e-12 |
5.542e-11 |
127 |
IMMUNE SYSTEM PROCESS |
300 |
1984 |
1.601e-12 |
5.867e-11 |
128 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
61 |
229 |
2.185e-12 |
7.944e-11 |
129 |
REGULATION OF GTPASE ACTIVITY |
129 |
673 |
2.25e-12 |
8.114e-11 |
130 |
POSITIVE REGULATION OF CELL ADHESION |
85 |
376 |
2.33e-12 |
8.34e-11 |
131 |
MUSCLE ORGAN DEVELOPMENT |
69 |
277 |
2.525e-12 |
8.968e-11 |
132 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
37 |
103 |
3.515e-12 |
1.239e-10 |
133 |
RESPONSE TO CYTOKINE |
134 |
714 |
4.029e-12 |
1.41e-10 |
134 |
REGULATION OF METAL ION TRANSPORT |
76 |
325 |
5.913e-12 |
2.053e-10 |
135 |
REGULATION OF HYDROLASE ACTIVITY |
215 |
1327 |
6.389e-12 |
2.186e-10 |
136 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
137 |
740 |
6.367e-12 |
2.186e-10 |
137 |
REGULATION OF BLOOD CIRCULATION |
71 |
295 |
7.024e-12 |
2.385e-10 |
138 |
CARTILAGE DEVELOPMENT |
45 |
147 |
1.044e-11 |
3.52e-10 |
139 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
295 |
1977 |
1.229e-11 |
4.113e-10 |
140 |
NEGATIVE REGULATION OF LOCOMOTION |
65 |
263 |
1.572e-11 |
5.226e-10 |
141 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
42 |
133 |
1.651e-11 |
5.447e-10 |
142 |
REGULATION OF RESPONSE TO STRESS |
231 |
1468 |
1.879e-11 |
6.157e-10 |
143 |
ACTIN FILAMENT BASED PROCESS |
94 |
450 |
1.915e-11 |
6.231e-10 |
144 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
48 |
167 |
2.655e-11 |
8.521e-10 |
145 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
71 |
303 |
2.653e-11 |
8.521e-10 |
146 |
REGULATION OF GROWTH |
120 |
633 |
2.844e-11 |
9.063e-10 |
147 |
STEM CELL DIFFERENTIATION |
52 |
190 |
3.045e-11 |
9.64e-10 |
148 |
POSITIVE REGULATION OF KINASE ACTIVITY |
98 |
482 |
3.591e-11 |
1.129e-09 |
149 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
59 |
232 |
3.935e-11 |
1.229e-09 |
150 |
HEAD DEVELOPMENT |
130 |
709 |
4.427e-11 |
1.373e-09 |
151 |
COGNITION |
62 |
251 |
4.726e-11 |
1.456e-09 |
152 |
REGULATION OF CELLULAR LOCALIZATION |
205 |
1277 |
4.874e-11 |
1.492e-09 |
153 |
RESPONSE TO MECHANICAL STIMULUS |
55 |
210 |
5.333e-11 |
1.622e-09 |
154 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
45 |
154 |
5.995e-11 |
1.8e-09 |
155 |
AMEBOIDAL TYPE CELL MIGRATION |
45 |
154 |
5.995e-11 |
1.8e-09 |
156 |
MORPHOGENESIS OF AN EPITHELIUM |
85 |
400 |
7.133e-11 |
2.128e-09 |
157 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
66 |
278 |
7.252e-11 |
2.149e-09 |
158 |
REGULATION OF ORGAN MORPHOGENESIS |
60 |
242 |
8.225e-11 |
2.422e-09 |
159 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
54 |
207 |
9.362e-11 |
2.74e-09 |
160 |
CELL PROJECTION ORGANIZATION |
155 |
902 |
9.625e-11 |
2.799e-09 |
161 |
MUSCLE CELL DIFFERENTIATION |
59 |
237 |
9.908e-11 |
2.864e-09 |
162 |
REGULATION OF CELL SUBSTRATE ADHESION |
48 |
173 |
1.033e-10 |
2.967e-09 |
163 |
SENSORY ORGAN DEVELOPMENT |
98 |
493 |
1.341e-10 |
3.827e-09 |
164 |
OSSIFICATION |
61 |
251 |
1.378e-10 |
3.911e-09 |
165 |
MUSCLE SYSTEM PROCESS |
66 |
282 |
1.396e-10 |
3.938e-09 |
166 |
REGULATION OF DEVELOPMENTAL GROWTH |
67 |
289 |
1.569e-10 |
4.399e-09 |
167 |
REGULATION OF CARTILAGE DEVELOPMENT |
26 |
63 |
1.612e-10 |
4.491e-09 |
168 |
NEURON PROJECTION GUIDANCE |
53 |
205 |
1.995e-10 |
5.524e-09 |
169 |
TUBE MORPHOGENESIS |
72 |
323 |
2.187e-10 |
6.021e-09 |
170 |
IMMUNE SYSTEM DEVELOPMENT |
110 |
582 |
2.331e-10 |
6.381e-09 |
171 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
36 |
112 |
2.611e-10 |
7.106e-09 |
172 |
CELL CELL SIGNALING |
135 |
767 |
3.285e-10 |
8.887e-09 |
173 |
MESENCHYMAL CELL DIFFERENTIATION |
40 |
134 |
3.38e-10 |
9.092e-09 |
174 |
EPITHELIAL CELL DIFFERENTIATION |
97 |
495 |
3.746e-10 |
1.002e-08 |
175 |
REGULATION OF CELL CELL ADHESION |
80 |
380 |
4.131e-10 |
1.098e-08 |
176 |
REGULATION OF CALCIUM ION TRANSPORT |
53 |
209 |
4.276e-10 |
1.13e-08 |
177 |
KIDNEY EPITHELIUM DEVELOPMENT |
38 |
125 |
5.188e-10 |
1.364e-08 |
178 |
CELL SUBSTRATE ADHESION |
45 |
164 |
5.829e-10 |
1.524e-08 |
179 |
GROWTH |
84 |
410 |
6.172e-10 |
1.604e-08 |
180 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
134 |
767 |
6.33e-10 |
1.636e-08 |
181 |
FOREBRAIN DEVELOPMENT |
76 |
357 |
6.631e-10 |
1.705e-08 |
182 |
NEGATIVE REGULATION OF GROWTH |
57 |
236 |
7.08e-10 |
1.81e-08 |
183 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
69 |
312 |
7.422e-10 |
1.883e-08 |
184 |
HEART MORPHOGENESIS |
53 |
212 |
7.447e-10 |
1.883e-08 |
185 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
86 |
426 |
8.287e-10 |
2.084e-08 |
186 |
REGULATION OF MUSCLE SYSTEM PROCESS |
50 |
195 |
8.781e-10 |
2.197e-08 |
187 |
REGULATION OF RESPONSE TO WOUNDING |
84 |
413 |
8.94e-10 |
2.213e-08 |
188 |
SKELETAL SYSTEM MORPHOGENESIS |
51 |
201 |
8.893e-10 |
2.213e-08 |
189 |
LEUKOCYTE ACTIVATION |
84 |
414 |
1.01e-09 |
2.487e-08 |
190 |
REGULATION OF IMMUNE SYSTEM PROCESS |
215 |
1403 |
1.115e-09 |
2.731e-08 |
191 |
RESPONSE TO ALCOHOL |
76 |
362 |
1.287e-09 |
3.119e-08 |
192 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
44 |
162 |
1.282e-09 |
3.119e-08 |
193 |
NEGATIVE REGULATION OF TRANSPORT |
90 |
458 |
1.401e-09 |
3.377e-08 |
194 |
REGULATION OF MEMBRANE POTENTIAL |
73 |
343 |
1.456e-09 |
3.492e-08 |
195 |
EMBRYONIC MORPHOGENESIS |
101 |
539 |
2.072e-09 |
4.944e-08 |
196 |
NEPHRON DEVELOPMENT |
35 |
115 |
2.39e-09 |
5.674e-08 |
197 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
110 |
606 |
2.585e-09 |
6.105e-08 |
198 |
REGULATION OF ERK1 AND ERK2 CASCADE |
56 |
238 |
2.784e-09 |
6.541e-08 |
199 |
MESONEPHROS DEVELOPMENT |
30 |
90 |
3.011e-09 |
7.041e-08 |
200 |
PHOSPHORYLATION |
191 |
1228 |
3.209e-09 |
7.444e-08 |
201 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
48 |
190 |
3.216e-09 |
7.444e-08 |
202 |
STRIATED MUSCLE CELL DIFFERENTIATION |
45 |
173 |
3.708e-09 |
8.542e-08 |
203 |
NEGATIVE REGULATION OF CELL DEATH |
145 |
872 |
3.909e-09 |
8.96e-08 |
204 |
CARDIOCYTE DIFFERENTIATION |
31 |
96 |
3.957e-09 |
9.025e-08 |
205 |
REGULATION OF HOMEOSTATIC PROCESS |
87 |
447 |
4.262e-09 |
9.673e-08 |
206 |
LEUKOCYTE DIFFERENTIATION |
64 |
292 |
4.426e-09 |
9.996e-08 |
207 |
REGULATION OF MAP KINASE ACTIVITY |
68 |
319 |
4.932e-09 |
1.109e-07 |
208 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
39 |
140 |
5.028e-09 |
1.125e-07 |
209 |
CELL PROLIFERATION |
118 |
672 |
5.081e-09 |
1.126e-07 |
210 |
NEGATIVE REGULATION OF CELL ADHESION |
53 |
223 |
5.068e-09 |
1.126e-07 |
211 |
REGULATION OF STEM CELL DIFFERENTIATION |
34 |
113 |
5.589e-09 |
1.232e-07 |
212 |
RESPONSE TO PURINE CONTAINING COMPOUND |
42 |
158 |
6.077e-09 |
1.334e-07 |
213 |
GLAND DEVELOPMENT |
79 |
395 |
6.25e-09 |
1.365e-07 |
214 |
EMBRYO DEVELOPMENT |
147 |
894 |
6.51e-09 |
1.415e-07 |
215 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
85 |
437 |
6.618e-09 |
1.426e-07 |
216 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
110 |
616 |
6.61e-09 |
1.426e-07 |
217 |
REGULATION OF PROTEIN LOCALIZATION |
154 |
950 |
7.535e-09 |
1.616e-07 |
218 |
RESPONSE TO STEROID HORMONE |
93 |
497 |
9.698e-09 |
2.07e-07 |
219 |
REGULATION OF TRANSFERASE ACTIVITY |
153 |
946 |
9.885e-09 |
2.1e-07 |
220 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
93 |
498 |
1.074e-08 |
2.272e-07 |
221 |
REGULATION OF CELL ACTIVATION |
91 |
484 |
1.102e-08 |
2.32e-07 |
222 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
89 |
470 |
1.124e-08 |
2.356e-07 |
223 |
TELENCEPHALON DEVELOPMENT |
53 |
228 |
1.145e-08 |
2.389e-07 |
224 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
39 |
144 |
1.193e-08 |
2.478e-07 |
225 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
150 |
926 |
1.251e-08 |
2.587e-07 |
226 |
ENDOTHELIUM DEVELOPMENT |
29 |
90 |
1.316e-08 |
2.71e-07 |
227 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
89 |
472 |
1.386e-08 |
2.841e-07 |
228 |
REGULATION OF CHEMOTAXIS |
45 |
180 |
1.395e-08 |
2.848e-07 |
229 |
POSITIVE REGULATION OF TRANSPORT |
151 |
936 |
1.47e-08 |
2.987e-07 |
230 |
CELLULAR RESPONSE TO ACID CHEMICAL |
44 |
175 |
1.675e-08 |
3.389e-07 |
231 |
ENDOTHELIAL CELL MIGRATION |
22 |
57 |
1.805e-08 |
3.636e-07 |
232 |
AMINOGLYCAN BIOSYNTHETIC PROCESS |
32 |
107 |
1.832e-08 |
3.674e-07 |
233 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
50 |
213 |
2.101e-08 |
4.179e-07 |
234 |
INOSITOL LIPID MEDIATED SIGNALING |
35 |
124 |
2.099e-08 |
4.179e-07 |
235 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
24 |
67 |
2.29e-08 |
4.534e-07 |
236 |
CHEMICAL HOMEOSTASIS |
142 |
874 |
2.572e-08 |
5.071e-07 |
237 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
141 |
867 |
2.712e-08 |
5.325e-07 |
238 |
REGULATION OF HEART CONTRACTION |
51 |
221 |
2.772e-08 |
5.419e-07 |
239 |
LEARNING |
36 |
131 |
2.848e-08 |
5.545e-07 |
240 |
CARDIAC MUSCLE CELL CONTRACTION |
15 |
29 |
2.975e-08 |
5.769e-07 |
241 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
29 |
93 |
3.008e-08 |
5.784e-07 |
242 |
DEVELOPMENTAL GROWTH |
68 |
333 |
3.008e-08 |
5.784e-07 |
243 |
REGULATION OF CELL JUNCTION ASSEMBLY |
24 |
68 |
3.194e-08 |
6.116e-07 |
244 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
64 |
307 |
3.384e-08 |
6.453e-07 |
245 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
66 |
321 |
3.634e-08 |
6.902e-07 |
246 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
20 |
50 |
3.926e-08 |
7.426e-07 |
247 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
41 |
162 |
4.176e-08 |
7.868e-07 |
248 |
TISSUE MIGRATION |
27 |
84 |
4.384e-08 |
8.225e-07 |
249 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
25 |
74 |
4.525e-08 |
8.456e-07 |
250 |
RESPONSE TO ORGANOPHOSPHORUS |
37 |
139 |
4.596e-08 |
8.554e-07 |
251 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
30 |
100 |
4.676e-08 |
8.669e-07 |
252 |
REGULATION OF SECRETION |
118 |
699 |
4.957e-08 |
9.152e-07 |
253 |
CELL DEATH |
157 |
1001 |
5.091e-08 |
9.363e-07 |
254 |
REGULATION OF CELL MATRIX ADHESION |
28 |
90 |
5.477e-08 |
1.003e-06 |
255 |
RESPONSE TO OXYGEN LEVELS |
64 |
311 |
5.63e-08 |
1.027e-06 |
256 |
MULTI MULTICELLULAR ORGANISM PROCESS |
49 |
213 |
5.722e-08 |
1.036e-06 |
257 |
RESPONSE TO OXIDATIVE STRESS |
70 |
352 |
5.72e-08 |
1.036e-06 |
258 |
ARTERY DEVELOPMENT |
25 |
75 |
6.125e-08 |
1.105e-06 |
259 |
PALLIUM DEVELOPMENT |
39 |
153 |
7.201e-08 |
1.294e-06 |
260 |
REGULATION OF INTRACELLULAR TRANSPORT |
107 |
621 |
7.286e-08 |
1.304e-06 |
261 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
44 |
184 |
8.195e-08 |
1.461e-06 |
262 |
CELLULAR RESPONSE TO PEPTIDE |
58 |
274 |
8.434e-08 |
1.498e-06 |
263 |
GLAND MORPHOGENESIS |
29 |
97 |
8.472e-08 |
1.499e-06 |
264 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
106 |
616 |
8.975e-08 |
1.582e-06 |
265 |
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL |
10 |
14 |
9.261e-08 |
1.626e-06 |
266 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
35 |
131 |
9.517e-08 |
1.665e-06 |
267 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
32 |
114 |
9.615e-08 |
1.676e-06 |
268 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
30 |
103 |
9.756e-08 |
1.694e-06 |
269 |
POSITIVE REGULATION OF ION TRANSPORT |
52 |
236 |
1.014e-07 |
1.755e-06 |
270 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
29 |
98 |
1.085e-07 |
1.871e-06 |
271 |
REGULATION OF WOUND HEALING |
34 |
126 |
1.112e-07 |
1.91e-06 |
272 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
36 |
138 |
1.21e-07 |
2.069e-06 |
273 |
CELL CHEMOTAXIS |
40 |
162 |
1.252e-07 |
2.134e-06 |
274 |
CYTOKINE MEDIATED SIGNALING PATHWAY |
83 |
452 |
1.405e-07 |
2.386e-06 |
275 |
GLIOGENESIS |
42 |
175 |
1.437e-07 |
2.432e-06 |
276 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
51 |
232 |
1.449e-07 |
2.443e-06 |
277 |
RENAL TUBULE DEVELOPMENT |
25 |
78 |
1.462e-07 |
2.455e-06 |
278 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
40 |
163 |
1.496e-07 |
2.503e-06 |
279 |
EYE DEVELOPMENT |
65 |
326 |
1.525e-07 |
2.543e-06 |
280 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
19 |
49 |
1.544e-07 |
2.565e-06 |
281 |
REGULATION OF PROTEIN SECRETION |
74 |
389 |
1.582e-07 |
2.62e-06 |
282 |
REGULATION OF ION HOMEOSTASIS |
46 |
201 |
1.695e-07 |
2.797e-06 |
283 |
RESPONSE TO PEPTIDE |
76 |
404 |
1.729e-07 |
2.843e-06 |
284 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
38 |
152 |
1.816e-07 |
2.976e-06 |
285 |
SPROUTING ANGIOGENESIS |
18 |
45 |
1.873e-07 |
3.058e-06 |
286 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
25 |
79 |
1.93e-07 |
3.14e-06 |
287 |
CELL PART MORPHOGENESIS |
107 |
633 |
1.96e-07 |
3.175e-06 |
288 |
LYMPHOCYTE ACTIVATION |
67 |
342 |
1.965e-07 |
3.175e-06 |
289 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
57 |
274 |
2.016e-07 |
3.246e-06 |
290 |
REGULATION OF MUSCLE CONTRACTION |
37 |
147 |
2.181e-07 |
3.487e-06 |
291 |
LYMPHOCYTE DIFFERENTIATION |
47 |
209 |
2.175e-07 |
3.487e-06 |
292 |
LEUKOCYTE CELL CELL ADHESION |
54 |
255 |
2.295e-07 |
3.658e-06 |
293 |
GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS |
13 |
25 |
2.337e-07 |
3.712e-06 |
294 |
HEART PROCESS |
26 |
85 |
2.36e-07 |
3.736e-06 |
295 |
CARDIAC MUSCLE CELL ACTION POTENTIAL |
16 |
37 |
2.488e-07 |
3.925e-06 |
296 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
44 |
191 |
2.56e-07 |
4.024e-06 |
297 |
REGULATION OF PEPTIDE TRANSPORT |
54 |
256 |
2.621e-07 |
4.107e-06 |
298 |
CHONDROCYTE DIFFERENTIATION |
21 |
60 |
2.7e-07 |
4.216e-06 |
299 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
18 |
46 |
2.781e-07 |
4.327e-06 |
300 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
29 |
102 |
2.806e-07 |
4.352e-06 |
301 |
CELL MATRIX ADHESION |
32 |
119 |
2.835e-07 |
4.383e-06 |
302 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
55 |
264 |
3.119e-07 |
4.794e-06 |
303 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
35 |
137 |
3.122e-07 |
4.794e-06 |
304 |
REGULATION OF LEUKOCYTE MIGRATION |
37 |
149 |
3.145e-07 |
4.813e-06 |
305 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
118 |
724 |
3.377e-07 |
5.152e-06 |
306 |
CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION |
12 |
22 |
3.471e-07 |
5.278e-06 |
307 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
29 |
103 |
3.523e-07 |
5.339e-06 |
308 |
REGULATION OF AXONOGENESIS |
40 |
168 |
3.534e-07 |
5.339e-06 |
309 |
BONE DEVELOPMENT |
38 |
156 |
3.712e-07 |
5.589e-06 |
310 |
CARDIAC CHAMBER DEVELOPMENT |
36 |
144 |
3.785e-07 |
5.681e-06 |
311 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
39 |
163 |
4.307e-07 |
6.443e-06 |
312 |
NEPHRON EPITHELIUM DEVELOPMENT |
27 |
93 |
4.513e-07 |
6.731e-06 |
313 |
MODULATION OF SYNAPTIC TRANSMISSION |
60 |
301 |
4.568e-07 |
6.791e-06 |
314 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
46 |
208 |
4.85e-07 |
7.188e-06 |
315 |
ENDOTHELIAL CELL DIFFERENTIATION |
23 |
72 |
4.883e-07 |
7.212e-06 |
316 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
31 |
116 |
5.021e-07 |
7.394e-06 |
317 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
22 |
67 |
5.047e-07 |
7.408e-06 |
318 |
REGULATION OF CYTOPLASMIC TRANSPORT |
85 |
481 |
5.45e-07 |
7.975e-06 |
319 |
REGULATION OF HORMONE SECRETION |
54 |
262 |
5.69e-07 |
8.282e-06 |
320 |
RESPONSE TO BMP |
27 |
94 |
5.713e-07 |
8.282e-06 |
321 |
CELLULAR RESPONSE TO BMP STIMULUS |
27 |
94 |
5.713e-07 |
8.282e-06 |
322 |
NEGATIVE REGULATION OF NEURON DEATH |
40 |
171 |
5.791e-07 |
8.368e-06 |
323 |
SYSTEM PROCESS |
247 |
1785 |
5.981e-07 |
8.616e-06 |
324 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
19 |
53 |
6.493e-07 |
9.255e-06 |
325 |
MESONEPHRIC TUBULE MORPHOGENESIS |
19 |
53 |
6.493e-07 |
9.255e-06 |
326 |
CELL JUNCTION ASSEMBLY |
33 |
129 |
6.504e-07 |
9.255e-06 |
327 |
SKELETAL MUSCLE CELL DIFFERENTIATION |
19 |
53 |
6.493e-07 |
9.255e-06 |
328 |
RESPONSE TO MONOAMINE |
15 |
35 |
6.816e-07 |
9.669e-06 |
329 |
AMINOGLYCAN METABOLIC PROCESS |
39 |
166 |
7.087e-07 |
1.002e-05 |
330 |
CELL JUNCTION ORGANIZATION |
42 |
185 |
7.201e-07 |
1.015e-05 |
331 |
ACTIN MEDIATED CELL CONTRACTION |
23 |
74 |
8.43e-07 |
1.185e-05 |
332 |
REGULATION OF HEMOPOIESIS |
61 |
314 |
9.165e-07 |
1.285e-05 |
333 |
REGULATION OF LEUKOCYTE PROLIFERATION |
45 |
206 |
9.237e-07 |
1.291e-05 |
334 |
MUSCLE CONTRACTION |
49 |
233 |
1.012e-06 |
1.41e-05 |
335 |
REGULATION OF CYTOKINE PRODUCTION |
95 |
563 |
1.024e-06 |
1.423e-05 |
336 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
15 |
36 |
1.057e-06 |
1.464e-05 |
337 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
74 |
408 |
1.073e-06 |
1.482e-05 |
338 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
23 |
75 |
1.098e-06 |
1.511e-05 |
339 |
REGULATION OF ACTIN FILAMENT BASED MOVEMENT |
14 |
32 |
1.187e-06 |
1.629e-05 |
340 |
RESPONSE TO DRUG |
77 |
431 |
1.198e-06 |
1.639e-05 |
341 |
SECRETION |
98 |
588 |
1.225e-06 |
1.672e-05 |
342 |
REGULATION OF KIDNEY DEVELOPMENT |
19 |
55 |
1.249e-06 |
1.695e-05 |
343 |
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY |
13 |
28 |
1.248e-06 |
1.695e-05 |
344 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
58 |
296 |
1.262e-06 |
1.708e-05 |
345 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
59 |
303 |
1.27e-06 |
1.713e-05 |
346 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
26 |
92 |
1.294e-06 |
1.741e-05 |
347 |
REGULATION OF BODY FLUID LEVELS |
87 |
506 |
1.318e-06 |
1.768e-05 |
348 |
NEGATIVE REGULATION OF CELL GROWTH |
39 |
170 |
1.342e-06 |
1.795e-05 |
349 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
31 |
121 |
1.356e-06 |
1.808e-05 |
350 |
REGULATION OF PROTEIN IMPORT |
41 |
183 |
1.397e-06 |
1.857e-05 |
351 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
45 |
209 |
1.406e-06 |
1.858e-05 |
352 |
REGULATION OF PEPTIDE SECRETION |
45 |
209 |
1.406e-06 |
1.858e-05 |
353 |
NEGATIVE REGULATION OF CELL ACTIVATION |
37 |
158 |
1.47e-06 |
1.938e-05 |
354 |
CARDIAC CHAMBER MORPHOGENESIS |
28 |
104 |
1.5e-06 |
1.966e-05 |
355 |
RESPONSE TO CAMP |
28 |
104 |
1.5e-06 |
1.966e-05 |
356 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
36 |
152 |
1.526e-06 |
1.994e-05 |
357 |
REGULATION OF HORMONE LEVELS |
83 |
478 |
1.535e-06 |
2.001e-05 |
358 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
111 |
691 |
1.542e-06 |
2.004e-05 |
359 |
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION |
15 |
37 |
1.608e-06 |
2.084e-05 |
360 |
ACTIN FILAMENT BASED MOVEMENT |
26 |
93 |
1.621e-06 |
2.096e-05 |
361 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
43 |
197 |
1.634e-06 |
2.1e-05 |
362 |
RESPIRATORY SYSTEM DEVELOPMENT |
43 |
197 |
1.634e-06 |
2.1e-05 |
363 |
HOMEOSTATIC PROCESS |
191 |
1337 |
1.644e-06 |
2.107e-05 |
364 |
CARDIAC CONDUCTION |
24 |
82 |
1.649e-06 |
2.108e-05 |
365 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
42 |
191 |
1.754e-06 |
2.236e-05 |
366 |
EMBRYONIC ORGAN DEVELOPMENT |
73 |
406 |
1.765e-06 |
2.244e-05 |
367 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
39 |
172 |
1.828e-06 |
2.317e-05 |
368 |
SIALYLATION |
11 |
21 |
1.853e-06 |
2.343e-05 |
369 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
46 |
218 |
1.944e-06 |
2.451e-05 |
370 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
33 |
135 |
1.953e-06 |
2.456e-05 |
371 |
MULTICELLULAR ORGANISMAL SIGNALING |
31 |
123 |
1.978e-06 |
2.481e-05 |
372 |
SECOND MESSENGER MEDIATED SIGNALING |
37 |
160 |
2.026e-06 |
2.535e-05 |
373 |
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT |
13 |
29 |
2.048e-06 |
2.555e-05 |
374 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT |
28 |
106 |
2.263e-06 |
2.816e-05 |
375 |
COLLAGEN FIBRIL ORGANIZATION |
15 |
38 |
2.403e-06 |
2.982e-05 |
376 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
24 |
84 |
2.647e-06 |
3.267e-05 |
377 |
POSITIVE REGULATION OF OSSIFICATION |
24 |
84 |
2.647e-06 |
3.267e-05 |
378 |
GANGLIOSIDE BIOSYNTHETIC PROCESS |
10 |
18 |
2.738e-06 |
3.37e-05 |
379 |
ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
21 |
68 |
2.81e-06 |
3.44e-05 |
380 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
21 |
68 |
2.81e-06 |
3.44e-05 |
381 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
72 |
404 |
2.883e-06 |
3.521e-05 |
382 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
52 |
262 |
2.971e-06 |
3.619e-05 |
383 |
RESPONSE TO INORGANIC SUBSTANCE |
82 |
479 |
3.139e-06 |
3.813e-05 |
384 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
159 |
1087 |
3.327e-06 |
4.031e-05 |
385 |
RESPONSE TO ACID CHEMICAL |
60 |
319 |
3.343e-06 |
4.032e-05 |
386 |
REGULATION OF CELL GROWTH |
70 |
391 |
3.345e-06 |
4.032e-05 |
387 |
POSITIVE REGULATION OF CHEMOTAXIS |
30 |
120 |
3.44e-06 |
4.135e-05 |
388 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
72 |
406 |
3.459e-06 |
4.149e-05 |
389 |
EMBRYO IMPLANTATION |
15 |
39 |
3.533e-06 |
4.225e-05 |
390 |
POSITIVE REGULATION OF CELL CELL ADHESION |
49 |
243 |
3.571e-06 |
4.26e-05 |
391 |
ION TRANSPORT |
180 |
1262 |
3.684e-06 |
4.384e-05 |
392 |
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
9 |
15 |
3.72e-06 |
4.415e-05 |
393 |
NEGATIVE REGULATION OF MAPK CASCADE |
34 |
145 |
3.737e-06 |
4.424e-05 |
394 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
20 |
64 |
3.933e-06 |
4.645e-05 |
395 |
NEURAL CREST CELL DIFFERENTIATION |
22 |
75 |
4.248e-06 |
5.004e-05 |
396 |
CELL ADHESION MEDIATED BY INTEGRIN |
8 |
12 |
4.354e-06 |
5.116e-05 |
397 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
67 |
372 |
4.365e-06 |
5.116e-05 |
398 |
REGULATION OF NEURON DEATH |
50 |
252 |
4.609e-06 |
5.389e-05 |
399 |
LEUKOCYTE MIGRATION |
51 |
259 |
4.665e-06 |
5.44e-05 |
400 |
WNT SIGNALING PATHWAY |
64 |
351 |
4.684e-06 |
5.448e-05 |
401 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
47 |
232 |
4.905e-06 |
5.692e-05 |
402 |
FORMATION OF PRIMARY GERM LAYER |
28 |
110 |
4.953e-06 |
5.733e-05 |
403 |
REGULATION OF NEURON APOPTOTIC PROCESS |
41 |
192 |
5.035e-06 |
5.813e-05 |
404 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
19 |
60 |
5.485e-06 |
6.317e-05 |
405 |
SECRETION BY CELL |
82 |
486 |
5.558e-06 |
6.37e-05 |
406 |
RESPONSE TO EXTRACELLULAR STIMULUS |
76 |
441 |
5.557e-06 |
6.37e-05 |
407 |
REGULATION OF CARDIAC MUSCLE CELL CONTRACTION |
12 |
27 |
5.688e-06 |
6.503e-05 |
408 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
17 |
50 |
5.77e-06 |
6.565e-05 |
409 |
LIPID PHOSPHORYLATION |
26 |
99 |
5.771e-06 |
6.565e-05 |
410 |
T CELL DIFFERENTIATION |
30 |
123 |
5.891e-06 |
6.686e-05 |
411 |
CEREBRAL CORTEX DEVELOPMENT |
27 |
105 |
5.916e-06 |
6.698e-05 |
412 |
KIDNEY MORPHOGENESIS |
23 |
82 |
5.986e-06 |
6.761e-05 |
413 |
NEGATIVE REGULATION OF SECRETION |
42 |
200 |
6.049e-06 |
6.815e-05 |
414 |
CELL FATE COMMITMENT |
46 |
227 |
6.11e-06 |
6.867e-05 |
415 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
97 |
602 |
6.133e-06 |
6.876e-05 |
416 |
HEMOSTASIS |
58 |
311 |
6.341e-06 |
7.092e-05 |
417 |
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION |
32 |
136 |
6.596e-06 |
7.343e-05 |
418 |
GLIAL CELL DIFFERENTIATION |
32 |
136 |
6.596e-06 |
7.343e-05 |
419 |
REGULATION OF VASOCONSTRICTION |
20 |
66 |
6.654e-06 |
7.389e-05 |
420 |
LOCOMOTORY BEHAVIOR |
39 |
181 |
6.768e-06 |
7.498e-05 |
421 |
REGULATION OF BMP SIGNALING PATHWAY |
22 |
77 |
6.828e-06 |
7.546e-05 |
422 |
FAT CELL DIFFERENTIATION |
27 |
106 |
7.165e-06 |
7.9e-05 |
423 |
MEMBRANE DEPOLARIZATION |
19 |
61 |
7.199e-06 |
7.919e-05 |
424 |
POSITIVE REGULATION OF KIDNEY DEVELOPMENT |
15 |
41 |
7.295e-06 |
7.987e-05 |
425 |
POSITIVE REGULATION OF RESPONSE TO WOUNDING |
36 |
162 |
7.281e-06 |
7.987e-05 |
426 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
33 |
143 |
7.422e-06 |
8.107e-05 |
427 |
PROTEOGLYCAN METABOLIC PROCESS |
23 |
83 |
7.478e-06 |
8.149e-05 |
428 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
35 |
156 |
7.757e-06 |
8.433e-05 |
429 |
ADIPOSE TISSUE DEVELOPMENT |
13 |
32 |
7.781e-06 |
8.44e-05 |
430 |
ARTERY MORPHOGENESIS |
17 |
51 |
7.826e-06 |
8.468e-05 |
431 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
49 |
250 |
8.113e-06 |
8.759e-05 |
432 |
EMBRYONIC ORGAN MORPHOGENESIS |
53 |
279 |
9.087e-06 |
9.765e-05 |
433 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
53 |
279 |
9.087e-06 |
9.765e-05 |
434 |
REGULATION OF MONOCYTE CHEMOTAXIS |
10 |
20 |
9.512e-06 |
0.000102 |
435 |
REGULATION OF ORGAN GROWTH |
21 |
73 |
9.767e-06 |
0.0001045 |
436 |
CELLULAR CHEMICAL HOMEOSTASIS |
92 |
570 |
9.87e-06 |
0.0001053 |
437 |
CYCLIC NUCLEOTIDE METABOLIC PROCESS |
18 |
57 |
1.006e-05 |
0.0001071 |
438 |
SYNAPSE ORGANIZATION |
33 |
145 |
1.014e-05 |
0.0001078 |
439 |
REGULATION OF CYTOPLASMIC TRANSLATION |
8 |
13 |
1.029e-05 |
0.0001091 |
440 |
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
27 |
108 |
1.041e-05 |
0.0001098 |
441 |
MUCOPOLYSACCHARIDE METABOLIC PROCESS |
27 |
108 |
1.041e-05 |
0.0001098 |
442 |
ORGAN GROWTH |
20 |
68 |
1.097e-05 |
0.0001155 |
443 |
REGULATION OF TRANSPORTER ACTIVITY |
41 |
198 |
1.111e-05 |
0.0001166 |
444 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
46 |
233 |
1.247e-05 |
0.0001306 |
445 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
27 |
109 |
1.249e-05 |
0.0001306 |
446 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
34 |
153 |
1.291e-05 |
0.0001347 |
447 |
POSITIVE REGULATION OF CELL ACTIVATION |
57 |
311 |
1.298e-05 |
0.0001351 |
448 |
PEPTIDYL TYROSINE MODIFICATION |
39 |
186 |
1.328e-05 |
0.0001379 |
449 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
14 |
38 |
1.338e-05 |
0.0001387 |
450 |
MUSCLE CELL DEVELOPMENT |
30 |
128 |
1.373e-05 |
0.0001419 |
451 |
NEGATIVE REGULATION OF OSSIFICATION |
20 |
69 |
1.396e-05 |
0.000144 |
452 |
NEURON MIGRATION |
27 |
110 |
1.494e-05 |
0.0001538 |
453 |
MEMORY |
25 |
98 |
1.501e-05 |
0.0001541 |
454 |
ION HOMEOSTASIS |
92 |
576 |
1.506e-05 |
0.0001541 |
455 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
26 |
104 |
1.507e-05 |
0.0001541 |
456 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
31 |
135 |
1.539e-05 |
0.000157 |
457 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
21 |
75 |
1.546e-05 |
0.0001574 |
458 |
METANEPHROS DEVELOPMENT |
22 |
81 |
1.661e-05 |
0.0001688 |
459 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
13 |
34 |
1.705e-05 |
0.0001721 |
460 |
RESPONSE TO FLUID SHEAR STRESS |
13 |
34 |
1.705e-05 |
0.0001721 |
461 |
CAMP METABOLIC PROCESS |
13 |
34 |
1.705e-05 |
0.0001721 |
462 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
64 |
365 |
1.71e-05 |
0.0001722 |
463 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
46 |
236 |
1.756e-05 |
0.0001765 |
464 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
20 |
70 |
1.766e-05 |
0.0001771 |
465 |
POSITIVE REGULATION OF BLOOD CIRCULATION |
24 |
93 |
1.792e-05 |
0.0001793 |
466 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
14 |
39 |
1.89e-05 |
0.0001883 |
467 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
14 |
39 |
1.89e-05 |
0.0001883 |
468 |
REGULATION OF CALCIUM MEDIATED SIGNALING |
21 |
76 |
1.93e-05 |
0.0001919 |
469 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
15 |
44 |
1.959e-05 |
0.0001943 |
470 |
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT |
32 |
143 |
1.975e-05 |
0.0001955 |
471 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
19 |
65 |
1.993e-05 |
0.0001969 |
472 |
REGULATION OF HEART RATE BY CARDIAC CONDUCTION |
12 |
30 |
2.105e-05 |
0.0002075 |
473 |
POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE |
8 |
14 |
2.182e-05 |
0.0002138 |
474 |
ACTION POTENTIAL |
24 |
94 |
2.173e-05 |
0.0002138 |
475 |
POSITIVE REGULATION OF SPROUTING ANGIOGENESIS |
8 |
14 |
2.182e-05 |
0.0002138 |
476 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
18 |
60 |
2.216e-05 |
0.0002166 |
477 |
NEGATIVE REGULATION OF CELL CELL ADHESION |
31 |
138 |
2.441e-05 |
0.0002381 |
478 |
SENSORY ORGAN MORPHOGENESIS |
46 |
239 |
2.45e-05 |
0.0002385 |
479 |
REGULATION OF TYPE 2 IMMUNE RESPONSE |
11 |
26 |
2.485e-05 |
0.0002409 |
480 |
GANGLIOSIDE METABOLIC PROCESS |
11 |
26 |
2.485e-05 |
0.0002409 |
481 |
REGULATION OF CARDIAC MUSCLE CONTRACTION |
19 |
66 |
2.53e-05 |
0.0002447 |
482 |
EPITHELIAL CELL PROLIFERATION |
23 |
89 |
2.596e-05 |
0.0002506 |
483 |
REGULATION OF EXTENT OF CELL GROWTH |
25 |
101 |
2.619e-05 |
0.0002523 |
484 |
ENDOCHONDRAL BONE MORPHOGENESIS |
15 |
45 |
2.659e-05 |
0.0002556 |
485 |
OSTEOBLAST DIFFERENTIATION |
29 |
126 |
2.729e-05 |
0.0002613 |
486 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
29 |
126 |
2.729e-05 |
0.0002613 |
487 |
CELLULAR RESPONSE TO INTERLEUKIN 6 |
10 |
22 |
2.74e-05 |
0.0002618 |
488 |
RHYTHMIC PROCESS |
54 |
298 |
3.003e-05 |
0.0002863 |
489 |
RESPONSE TO TOXIC SUBSTANCE |
46 |
241 |
3.045e-05 |
0.0002898 |
490 |
REGULATION OF PLATELET ACTIVATION |
12 |
31 |
3.112e-05 |
0.0002949 |
491 |
REGULATION OF SYNAPTIC VESICLE TRANSPORT |
12 |
31 |
3.112e-05 |
0.0002949 |
492 |
EPITHELIAL CELL DEVELOPMENT |
38 |
186 |
3.135e-05 |
0.0002965 |
493 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
39 |
193 |
3.218e-05 |
0.0003037 |
494 |
REGULATION OF NEUROTRANSMITTER SECRETION |
16 |
51 |
3.395e-05 |
0.0003198 |
495 |
POSITIVE REGULATION OF STAT CASCADE |
20 |
73 |
3.46e-05 |
0.0003246 |
496 |
POSITIVE REGULATION OF JAK STAT CASCADE |
20 |
73 |
3.46e-05 |
0.0003246 |
497 |
CELLULAR HOMEOSTASIS |
103 |
676 |
3.573e-05 |
0.0003345 |
498 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
14 |
41 |
3.618e-05 |
0.000338 |
499 |
BONE MORPHOGENESIS |
21 |
79 |
3.648e-05 |
0.0003402 |
500 |
CARDIAC SEPTUM DEVELOPMENT |
22 |
85 |
3.761e-05 |
0.00035 |
501 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
28 |
122 |
3.934e-05 |
0.0003654 |
502 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
38 |
188 |
4.012e-05 |
0.0003704 |
503 |
NERVE DEVELOPMENT |
19 |
68 |
4.004e-05 |
0.0003704 |
504 |
CELLULAR LIPID METABOLIC PROCESS |
132 |
913 |
4e-05 |
0.0003704 |
505 |
EAR DEVELOPMENT |
39 |
195 |
4.095e-05 |
0.0003766 |
506 |
REGULATION OF INFLAMMATORY RESPONSE |
53 |
294 |
4.092e-05 |
0.0003766 |
507 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
42 |
216 |
4.231e-05 |
0.0003883 |
508 |
PLATELET ACTIVATION |
31 |
142 |
4.388e-05 |
0.0004014 |
509 |
REGULATION OF OSTEOBLAST PROLIFERATION |
10 |
23 |
4.399e-05 |
0.0004014 |
510 |
INNERVATION |
10 |
23 |
4.399e-05 |
0.0004014 |
511 |
ACTIVATION OF MAPKK ACTIVITY |
16 |
52 |
4.437e-05 |
0.000404 |
512 |
ENDOCARDIAL CUSHION DEVELOPMENT |
12 |
32 |
4.513e-05 |
0.0004101 |
513 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
34 |
162 |
4.526e-05 |
0.0004106 |
514 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
22 |
86 |
4.566e-05 |
0.0004133 |
515 |
REGULATION OF MUSCLE ADAPTATION |
18 |
63 |
4.584e-05 |
0.0004142 |
516 |
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION |
9 |
19 |
4.667e-05 |
0.0004209 |
517 |
LIPID MODIFICATION |
41 |
210 |
4.71e-05 |
0.0004233 |
518 |
REGULATION OF BLOOD PRESSURE |
35 |
169 |
4.713e-05 |
0.0004233 |
519 |
POSITIVE REGULATION OF DEPHOSPHORYLATION |
15 |
47 |
4.747e-05 |
0.0004255 |
520 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
87 |
554 |
4.786e-05 |
0.0004283 |
521 |
REGULATION OF RECEPTOR ACTIVITY |
27 |
117 |
4.845e-05 |
0.0004327 |
522 |
LIPID METABOLIC PROCESS |
161 |
1158 |
4.864e-05 |
0.0004327 |
523 |
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
13 |
37 |
4.862e-05 |
0.0004327 |
524 |
REGULATION OF HEART GROWTH |
14 |
42 |
4.913e-05 |
0.0004363 |
525 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
33 |
156 |
4.934e-05 |
0.0004369 |
526 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
63 |
370 |
4.939e-05 |
0.0004369 |
527 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
37 |
183 |
5.002e-05 |
0.00044 |
528 |
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT |
19 |
69 |
4.995e-05 |
0.00044 |
529 |
POSITIVE REGULATION OF AXONOGENESIS |
19 |
69 |
4.995e-05 |
0.00044 |
530 |
INFLAMMATORY RESPONSE |
74 |
454 |
5.119e-05 |
0.0004494 |
531 |
PROTEOGLYCAN BIOSYNTHETIC PROCESS |
17 |
58 |
5.178e-05 |
0.0004537 |
532 |
SENSORY PERCEPTION OF PAIN |
20 |
75 |
5.282e-05 |
0.000462 |
533 |
GLUCOSE HOMEOSTASIS |
35 |
170 |
5.354e-05 |
0.0004665 |
534 |
CARBOHYDRATE HOMEOSTASIS |
35 |
170 |
5.354e-05 |
0.0004665 |
535 |
STRIATED MUSCLE CONTRACTION |
24 |
99 |
5.411e-05 |
0.000468 |
536 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
24 |
99 |
5.411e-05 |
0.000468 |
537 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
24 |
99 |
5.411e-05 |
0.000468 |
538 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
24 |
99 |
5.411e-05 |
0.000468 |
539 |
REGULATION OF SPROUTING ANGIOGENESIS |
11 |
28 |
5.679e-05 |
0.0004902 |
540 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
16 |
53 |
5.751e-05 |
0.0004955 |
541 |
MUSCLE ORGAN MORPHOGENESIS |
19 |
70 |
6.199e-05 |
0.0005321 |
542 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
19 |
70 |
6.199e-05 |
0.0005321 |
543 |
REGULATION OF FAT CELL DIFFERENTIATION |
25 |
106 |
6.219e-05 |
0.0005329 |
544 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
15 |
48 |
6.249e-05 |
0.0005335 |
545 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
15 |
48 |
6.249e-05 |
0.0005335 |
546 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
59 |
343 |
6.296e-05 |
0.0005365 |
547 |
RESPONSE TO VITAMIN D |
12 |
33 |
6.427e-05 |
0.000546 |
548 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
24 |
100 |
6.431e-05 |
0.000546 |
549 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
42 |
220 |
6.571e-05 |
0.0005566 |
550 |
VASCULOGENESIS |
17 |
59 |
6.579e-05 |
0.0005566 |
551 |
CERAMIDE BIOSYNTHETIC PROCESS |
14 |
43 |
6.597e-05 |
0.0005571 |
552 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
21 |
82 |
6.624e-05 |
0.0005584 |
553 |
REGULATION OF STEM CELL PROLIFERATION |
22 |
88 |
6.651e-05 |
0.0005597 |
554 |
REGULATION OF CELL SIZE |
35 |
172 |
6.879e-05 |
0.0005777 |
555 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
60 |
352 |
7.152e-05 |
0.0005996 |
556 |
DEVELOPMENTAL MATURATION |
38 |
193 |
7.262e-05 |
0.0006077 |
557 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
25 |
107 |
7.329e-05 |
0.000609 |
558 |
REGULATION OF T CELL DIFFERENTIATION |
25 |
107 |
7.329e-05 |
0.000609 |
559 |
REGULATION OF JNK CASCADE |
33 |
159 |
7.321e-05 |
0.000609 |
560 |
PLATELET DEGRANULATION |
25 |
107 |
7.329e-05 |
0.000609 |
561 |
IMMUNE RESPONSE |
153 |
1100 |
7.344e-05 |
0.0006091 |
562 |
AGING |
48 |
264 |
7.423e-05 |
0.0006146 |
563 |
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY |
9 |
20 |
7.707e-05 |
0.0006367 |
564 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
8 |
16 |
7.731e-05 |
0.0006367 |
565 |
RESPONSE TO EPINEPHRINE |
8 |
16 |
7.731e-05 |
0.0006367 |
566 |
NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
23 |
95 |
7.844e-05 |
0.0006426 |
567 |
REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
23 |
95 |
7.844e-05 |
0.0006426 |
568 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
23 |
95 |
7.844e-05 |
0.0006426 |
569 |
SPHINGOLIPID BIOSYNTHETIC PROCESS |
20 |
77 |
7.912e-05 |
0.000647 |
570 |
RESPONSE TO HEAT |
22 |
89 |
7.983e-05 |
0.0006505 |
571 |
POST EMBRYONIC DEVELOPMENT |
22 |
89 |
7.983e-05 |
0.0006505 |
572 |
GLOMERULUS DEVELOPMENT |
15 |
49 |
8.151e-05 |
0.0006619 |
573 |
CARDIAC SEPTUM MORPHOGENESIS |
15 |
49 |
8.151e-05 |
0.0006619 |
574 |
REGULATION OF SMOOTH MUSCLE CONTRACTION |
17 |
60 |
8.304e-05 |
0.0006732 |
575 |
REGULATION OF CATABOLIC PROCESS |
108 |
731 |
8.407e-05 |
0.0006803 |
576 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
14 |
44 |
8.761e-05 |
0.0007077 |
577 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
12 |
34 |
9.002e-05 |
0.0007173 |
578 |
REGULATION OF WNT SIGNALING PATHWAY |
54 |
310 |
8.991e-05 |
0.0007173 |
579 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
12 |
34 |
9.002e-05 |
0.0007173 |
580 |
SEX DIFFERENTIATION |
48 |
266 |
8.991e-05 |
0.0007173 |
581 |
HEART VALVE DEVELOPMENT |
12 |
34 |
9.002e-05 |
0.0007173 |
582 |
EXOCYTOSIS |
54 |
310 |
8.991e-05 |
0.0007173 |
583 |
NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION |
24 |
102 |
8.999e-05 |
0.0007173 |
584 |
RENAL SYSTEM PROCESS |
24 |
102 |
8.999e-05 |
0.0007173 |
585 |
REGULATION OF LEUKOCYTE CHEMOTAXIS |
23 |
96 |
9.319e-05 |
0.0007412 |
586 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
26 |
115 |
9.544e-05 |
0.0007553 |
587 |
CELLULAR RESPONSE TO ALCOHOL |
26 |
115 |
9.544e-05 |
0.0007553 |
588 |
RESPONSE TO CALCIUM ION |
26 |
115 |
9.544e-05 |
0.0007553 |
589 |
LYMPHOCYTE COSTIMULATION |
20 |
78 |
9.618e-05 |
0.0007598 |
590 |
RESPONSE TO KETONE |
36 |
182 |
0.0001006 |
0.0007933 |
591 |
POSITIVE REGULATION OF LEUKOCYTE MIGRATION |
25 |
109 |
0.0001009 |
0.0007947 |
592 |
CELL GROWTH |
29 |
135 |
0.0001033 |
0.000812 |
593 |
MEMBRANE ASSEMBLY |
10 |
25 |
0.0001035 |
0.0008123 |
594 |
GASTRULATION |
32 |
155 |
0.0001038 |
0.000813 |
595 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
27 |
122 |
0.000104 |
0.0008133 |
596 |
REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
15 |
50 |
0.0001054 |
0.0008216 |
597 |
CELLULAR RESPONSE TO CAMP |
15 |
50 |
0.0001054 |
0.0008216 |
598 |
REGULATION OF CALCIUM ION IMPORT |
24 |
103 |
0.000106 |
0.0008247 |
599 |
PATTERN SPECIFICATION PROCESS |
68 |
418 |
0.0001075 |
0.000835 |
600 |
POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
23 |
97 |
0.0001104 |
0.0008558 |
601 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
41 |
218 |
0.0001125 |
0.0008712 |
602 |
REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
40 |
211 |
0.0001135 |
0.0008755 |
603 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
40 |
211 |
0.0001135 |
0.0008755 |
604 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
21 |
85 |
0.0001159 |
0.000893 |
605 |
DENDRITE DEVELOPMENT |
20 |
79 |
0.0001164 |
0.0008953 |
606 |
MEMBRANE BIOGENESIS |
11 |
30 |
0.0001188 |
0.0009124 |
607 |
PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
7 |
13 |
0.0001221 |
0.0009331 |
608 |
NEGATIVE REGULATION OF ORGAN GROWTH |
9 |
21 |
0.0001225 |
0.0009331 |
609 |
REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS |
9 |
21 |
0.0001225 |
0.0009331 |
610 |
LYMPH VESSEL MORPHOGENESIS |
7 |
13 |
0.0001221 |
0.0009331 |
611 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
13 |
40 |
0.0001221 |
0.0009331 |
612 |
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS |
76 |
482 |
0.0001231 |
0.0009362 |
613 |
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT |
26 |
117 |
0.000129 |
0.0009791 |
614 |
FOREBRAIN CELL MIGRATION |
17 |
62 |
0.0001298 |
0.0009821 |
615 |
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION |
17 |
62 |
0.0001298 |
0.0009821 |
616 |
REGULATION OF CELLULAR COMPONENT SIZE |
57 |
337 |
0.0001325 |
0.001001 |
617 |
REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
8 |
17 |
0.0001328 |
0.001001 |
618 |
CYTOSKELETON ORGANIZATION |
120 |
838 |
0.0001336 |
0.001006 |
619 |
NEURAL CREST CELL MIGRATION |
15 |
51 |
0.0001352 |
0.001013 |
620 |
NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
15 |
51 |
0.0001352 |
0.001013 |
621 |
CELLULAR RESPONSE TO FATTY ACID |
15 |
51 |
0.0001352 |
0.001013 |
622 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN |
18 |
68 |
0.0001364 |
0.001019 |
623 |
MULTICELLULAR ORGANISMAL RESPONSE TO STRESS |
18 |
68 |
0.0001364 |
0.001019 |
624 |
REGULATION OF HEART RATE |
21 |
86 |
0.0001386 |
0.001034 |
625 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
30 |
144 |
0.0001419 |
0.001056 |
626 |
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
28 |
131 |
0.0001476 |
0.001097 |
627 |
MESODERM DEVELOPMENT |
26 |
118 |
0.0001494 |
0.001109 |
628 |
RESPONSE TO INTERLEUKIN 6 |
10 |
26 |
0.0001527 |
0.00113 |
629 |
REGULATION OF P38MAPK CASCADE |
10 |
26 |
0.0001527 |
0.00113 |
630 |
REGULATION OF OSTEOCLAST DIFFERENTIATION |
17 |
63 |
0.0001608 |
0.001186 |
631 |
NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
17 |
63 |
0.0001608 |
0.001186 |
632 |
AORTA DEVELOPMENT |
13 |
41 |
0.000162 |
0.001193 |
633 |
TISSUE REMODELING |
21 |
87 |
0.0001652 |
0.001214 |
634 |
CARDIAC ATRIUM DEVELOPMENT |
11 |
31 |
0.0001671 |
0.001222 |
635 |
GLYCOSPHINGOLIPID METABOLIC PROCESS |
18 |
69 |
0.0001669 |
0.001222 |
636 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
11 |
31 |
0.0001671 |
0.001222 |
637 |
POSITIVE REGULATION OF AXON EXTENSION |
12 |
36 |
0.0001689 |
0.00123 |
638 |
NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT |
12 |
36 |
0.0001689 |
0.00123 |
639 |
NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
12 |
36 |
0.0001689 |
0.00123 |
640 |
CARDIAC VENTRICLE DEVELOPMENT |
24 |
106 |
0.0001702 |
0.001237 |
641 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
15 |
52 |
0.000172 |
0.001249 |
642 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
33 |
166 |
0.0001739 |
0.00126 |
643 |
RESPONSE TO METAL ION |
56 |
333 |
0.0001762 |
0.001275 |
644 |
PEPTIDYL TYROSINE DEPHOSPHORYLATION |
23 |
100 |
0.0001799 |
0.0013 |
645 |
REGULATION OF SYNAPSE ORGANIZATION |
25 |
113 |
0.0001855 |
0.001338 |
646 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
148 |
1079 |
0.0001858 |
0.001338 |
647 |
REGULATION OF COAGULATION |
21 |
88 |
0.0001961 |
0.00141 |
648 |
REGULATION OF LIPID METABOLIC PROCESS |
49 |
282 |
0.0001976 |
0.001419 |
649 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
51 |
297 |
0.0001998 |
0.001432 |
650 |
EXTRACELLULAR MATRIX DISASSEMBLY |
19 |
76 |
0.0002041 |
0.001461 |
651 |
ION TRANSMEMBRANE TRANSPORT |
117 |
822 |
0.0002062 |
0.001474 |
652 |
REGULATED EXOCYTOSIS |
41 |
224 |
0.0002069 |
0.001477 |
653 |
DIVALENT INORGANIC CATION TRANSPORT |
47 |
268 |
0.0002118 |
0.001509 |
654 |
DENDRITE MORPHOGENESIS |
13 |
42 |
0.0002126 |
0.001513 |
655 |
RESPONSE TO STARVATION |
31 |
154 |
0.0002133 |
0.001515 |
656 |
REGULATION OF EMBRYONIC DEVELOPMENT |
25 |
114 |
0.0002146 |
0.001522 |
657 |
REGULATION OF BINDING |
49 |
283 |
0.0002155 |
0.001526 |
658 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
8 |
18 |
0.0002174 |
0.001528 |
659 |
PLASMA MEMBRANE ORGANIZATION |
38 |
203 |
0.0002171 |
0.001528 |
660 |
ATRIAL SEPTUM DEVELOPMENT |
8 |
18 |
0.0002174 |
0.001528 |
661 |
SMOOTH MUSCLE TISSUE DEVELOPMENT |
8 |
18 |
0.0002174 |
0.001528 |
662 |
KIDNEY MESENCHYME DEVELOPMENT |
8 |
18 |
0.0002174 |
0.001528 |
663 |
REGULATION OF PROTEIN BINDING |
33 |
168 |
0.0002196 |
0.001536 |
664 |
POSITIVE REGULATION OF HEART GROWTH |
10 |
27 |
0.0002202 |
0.001536 |
665 |
RESPONSE TO CARBOHYDRATE |
33 |
168 |
0.0002196 |
0.001536 |
666 |
SUBSTRATE DEPENDENT CELL MIGRATION |
10 |
27 |
0.0002202 |
0.001536 |
667 |
HETEROTYPIC CELL CELL ADHESION |
10 |
27 |
0.0002202 |
0.001536 |
668 |
HOMEOSTASIS OF NUMBER OF CELLS |
34 |
175 |
0.000221 |
0.001539 |
669 |
POSITIVE REGULATION OF METANEPHROS DEVELOPMENT |
7 |
14 |
0.0002225 |
0.00154 |
670 |
ATRIAL SEPTUM MORPHOGENESIS |
7 |
14 |
0.0002225 |
0.00154 |
671 |
METANEPHRIC MESENCHYME DEVELOPMENT |
7 |
14 |
0.0002225 |
0.00154 |
672 |
POSITIVE REGULATION OF FATTY ACID OXIDATION |
7 |
14 |
0.0002225 |
0.00154 |
673 |
AXON EXTENSION |
12 |
37 |
0.0002266 |
0.001566 |
674 |
SALIVARY GLAND DEVELOPMENT |
11 |
32 |
0.0002309 |
0.001587 |
675 |
REGULATION OF ORGAN FORMATION |
11 |
32 |
0.0002309 |
0.001587 |
676 |
NEGATIVE REGULATION OF PROTEIN SECRETION |
24 |
108 |
0.0002303 |
0.001587 |
677 |
METANEPHRIC NEPHRON DEVELOPMENT |
11 |
32 |
0.0002309 |
0.001587 |
678 |
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
16 |
59 |
0.0002334 |
0.001602 |
679 |
RESPONSE TO TEMPERATURE STIMULUS |
30 |
148 |
0.0002357 |
0.001615 |
680 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
37 |
197 |
0.0002436 |
0.001667 |
681 |
RESPONSE TO CORTICOSTEROID |
34 |
176 |
0.0002472 |
0.001673 |
682 |
REGULATION OF MYOBLAST DIFFERENTIATION |
14 |
48 |
0.0002473 |
0.001673 |
683 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
19 |
77 |
0.000245 |
0.001673 |
684 |
MYOFIBRIL ASSEMBLY |
14 |
48 |
0.0002473 |
0.001673 |
685 |
NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
18 |
71 |
0.0002463 |
0.001673 |
686 |
PROTEIN DEPHOSPHORYLATION |
36 |
190 |
0.0002457 |
0.001673 |
687 |
POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
14 |
48 |
0.0002473 |
0.001673 |
688 |
REGULATION OF PROTEIN TARGETING |
52 |
307 |
0.000246 |
0.001673 |
689 |
RESPONSE TO INTERLEUKIN 1 |
25 |
115 |
0.0002477 |
0.001673 |
690 |
NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
28 |
135 |
0.0002516 |
0.001697 |
691 |
METAL ION TRANSPORT |
87 |
582 |
0.00027 |
0.001818 |
692 |
DEPHOSPHORYLATION |
49 |
286 |
0.0002782 |
0.001871 |
693 |
RESPONSE TO AUDITORY STIMULUS |
9 |
23 |
0.0002812 |
0.001885 |
694 |
REGULATION OF METANEPHROS DEVELOPMENT |
9 |
23 |
0.0002812 |
0.001885 |
695 |
NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
28 |
136 |
0.0002861 |
0.001916 |
696 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
16 |
60 |
0.0002881 |
0.001926 |
697 |
POSITIVE REGULATION OF SECRETION |
60 |
370 |
0.0002893 |
0.001931 |
698 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
17 |
66 |
0.0002959 |
0.001967 |
699 |
MESODERM MORPHOGENESIS |
17 |
66 |
0.0002959 |
0.001967 |
700 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
17 |
66 |
0.0002959 |
0.001967 |
701 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
12 |
38 |
0.0003002 |
0.001982 |
702 |
CELLULAR RESPONSE TO GLUCAGON STIMULUS |
12 |
38 |
0.0003002 |
0.001982 |
703 |
REGULATION OF ACTION POTENTIAL |
12 |
38 |
0.0003002 |
0.001982 |
704 |
MESENCHYME MORPHOGENESIS |
12 |
38 |
0.0003002 |
0.001982 |
705 |
POSITIVE REGULATION OF ORGAN GROWTH |
12 |
38 |
0.0003002 |
0.001982 |
706 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
83 |
552 |
0.0003059 |
0.002016 |
707 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION |
24 |
110 |
0.0003083 |
0.002029 |
708 |
LEUKOCYTE CHEMOTAXIS |
25 |
117 |
0.0003277 |
0.002154 |
709 |
PALATE DEVELOPMENT |
20 |
85 |
0.0003366 |
0.002209 |
710 |
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL |
15 |
55 |
0.000339 |
0.002222 |
711 |
KIDNEY VASCULATURE DEVELOPMENT |
8 |
19 |
0.0003416 |
0.002232 |
712 |
RENAL SYSTEM VASCULATURE DEVELOPMENT |
8 |
19 |
0.0003416 |
0.002232 |
713 |
REGULATION OF STRIATED MUSCLE CONTRACTION |
19 |
79 |
0.0003488 |
0.002276 |
714 |
REGULATION OF T HELPER 2 CELL DIFFERENTIATION |
6 |
11 |
0.0003538 |
0.002306 |
715 |
NEGATIVE REGULATION OF MAP KINASE ACTIVITY |
18 |
73 |
0.0003567 |
0.002307 |
716 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
22 |
98 |
0.0003545 |
0.002307 |
717 |
POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
27 |
131 |
0.0003574 |
0.002307 |
718 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
24 |
111 |
0.0003554 |
0.002307 |
719 |
CERAMIDE METABOLIC PROCESS |
18 |
73 |
0.0003567 |
0.002307 |
720 |
RETINA DEVELOPMENT IN CAMERA TYPE EYE |
27 |
131 |
0.0003574 |
0.002307 |
721 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
18 |
73 |
0.0003567 |
0.002307 |
722 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
25 |
118 |
0.0003757 |
0.002418 |
723 |
ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
29 |
145 |
0.0003757 |
0.002418 |
724 |
POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS |
7 |
15 |
0.0003799 |
0.002438 |
725 |
VENOUS BLOOD VESSEL DEVELOPMENT |
7 |
15 |
0.0003799 |
0.002438 |
726 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
39 |
216 |
0.0003875 |
0.002483 |
727 |
POSITIVE REGULATION OF GROWTH |
42 |
238 |
0.0003906 |
0.0025 |
728 |
NEGATIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
12 |
39 |
0.0003932 |
0.002507 |
729 |
ASTROCYTE DIFFERENTIATION |
12 |
39 |
0.0003932 |
0.002507 |
730 |
NEGATIVE CHEMOTAXIS |
12 |
39 |
0.0003932 |
0.002507 |
731 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
27 |
132 |
0.0004058 |
0.002583 |
732 |
CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS |
9 |
24 |
0.0004088 |
0.002585 |
733 |
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
9 |
24 |
0.0004088 |
0.002585 |
734 |
REGULATION OF ODONTOGENESIS |
9 |
24 |
0.0004088 |
0.002585 |
735 |
EAR MORPHOGENESIS |
24 |
112 |
0.0004087 |
0.002585 |
736 |
NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
9 |
24 |
0.0004088 |
0.002585 |
737 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
19 |
80 |
0.0004138 |
0.002612 |
738 |
REGULATION OF CELL SHAPE |
28 |
139 |
0.0004161 |
0.002623 |
739 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
15 |
56 |
0.0004193 |
0.002629 |
740 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
15 |
56 |
0.0004193 |
0.002629 |
741 |
REGULATION OF DENDRITIC SPINE DEVELOPMENT |
15 |
56 |
0.0004193 |
0.002629 |
742 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
15 |
56 |
0.0004193 |
0.002629 |
743 |
ADHERENS JUNCTION ASSEMBLY |
11 |
34 |
0.0004215 |
0.00264 |
744 |
RESPONSE TO ESTRADIOL |
29 |
146 |
0.0004233 |
0.002648 |
745 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
10 |
29 |
0.0004309 |
0.002688 |
746 |
RESPONSE TO ISCHEMIA |
10 |
29 |
0.0004309 |
0.002688 |
747 |
REGULATION OF ALPHA BETA T CELL ACTIVATION |
17 |
68 |
0.000433 |
0.002697 |
748 |
CATION TRANSPORT |
112 |
796 |
0.0004337 |
0.002698 |
749 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
21 |
93 |
0.0004397 |
0.002731 |
750 |
GLYCOPROTEIN METABOLIC PROCESS |
57 |
353 |
0.000451 |
0.002798 |
751 |
ENDOTHELIAL CELL DEVELOPMENT |
13 |
45 |
0.0004527 |
0.002801 |
752 |
REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS |
13 |
45 |
0.0004527 |
0.002801 |
753 |
MYELOID CELL DIFFERENTIATION |
35 |
189 |
0.0004643 |
0.002869 |
754 |
RESPONSE TO ESTROGEN |
39 |
218 |
0.0004683 |
0.002886 |
755 |
PROTEIN LOCALIZATION |
229 |
1805 |
0.0004678 |
0.002886 |
756 |
POSITIVE REGULATION OF PROTEIN SECRETION |
38 |
211 |
0.0004809 |
0.00296 |
757 |
CYTOKINE PRODUCTION |
25 |
120 |
0.0004903 |
0.00301 |
758 |
REGULATION OF DENDRITE DEVELOPMENT |
25 |
120 |
0.0004903 |
0.00301 |
759 |
MULTI ORGANISM BEHAVIOR |
18 |
75 |
0.0005077 |
0.003112 |
760 |
LYMPH VESSEL DEVELOPMENT |
8 |
20 |
0.0005179 |
0.003171 |
761 |
INTERACTION WITH HOST |
27 |
134 |
0.0005203 |
0.003181 |
762 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
58 |
363 |
0.0005297 |
0.003234 |
763 |
APPENDAGE DEVELOPMENT |
32 |
169 |
0.000534 |
0.003252 |
764 |
LIMB DEVELOPMENT |
32 |
169 |
0.000534 |
0.003252 |
765 |
DIGESTIVE SYSTEM DEVELOPMENT |
29 |
148 |
0.0005349 |
0.003253 |
766 |
SENSORY PERCEPTION OF MECHANICAL STIMULUS |
30 |
155 |
0.0005373 |
0.003259 |
767 |
REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
30 |
155 |
0.0005373 |
0.003259 |
768 |
OVULATION CYCLE PROCESS |
20 |
88 |
0.0005451 |
0.003302 |
769 |
REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES |
11 |
35 |
0.0005578 |
0.003375 |
770 |
PHOSPHOLIPID METABOLIC PROCESS |
58 |
364 |
0.000568 |
0.003432 |
771 |
REGULATION OF PHOSPHATASE ACTIVITY |
26 |
128 |
0.0005752 |
0.00347 |
772 |
NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
19 |
82 |
0.0005756 |
0.00347 |
773 |
RESPONSE TO BIOTIC STIMULUS |
122 |
886 |
0.0005769 |
0.003472 |
774 |
CHONDROITIN SULFATE BIOSYNTHETIC PROCESS |
9 |
25 |
0.0005806 |
0.00349 |
775 |
NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY |
10 |
30 |
0.0005869 |
0.003506 |
776 |
POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION |
10 |
30 |
0.0005869 |
0.003506 |
777 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
10 |
30 |
0.0005869 |
0.003506 |
778 |
REGULATION OF MEMBRANE REPOLARIZATION |
10 |
30 |
0.0005869 |
0.003506 |
779 |
LAMELLIPODIUM ASSEMBLY |
10 |
30 |
0.0005869 |
0.003506 |
780 |
CANONICAL WNT SIGNALING PATHWAY |
21 |
95 |
0.0005942 |
0.003544 |
781 |
NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE |
14 |
52 |
0.0006109 |
0.00364 |
782 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
7 |
16 |
0.0006153 |
0.003661 |
783 |
INTERFERON GAMMA MEDIATED SIGNALING PATHWAY |
17 |
70 |
0.0006215 |
0.003693 |
784 |
NEGATIVE REGULATION OF WOUND HEALING |
15 |
58 |
0.0006296 |
0.003736 |
785 |
CELLULAR RESPONSE TO EPINEPHRINE STIMULUS |
6 |
12 |
0.0006458 |
0.003818 |
786 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
6 |
12 |
0.0006458 |
0.003818 |
787 |
MECHANOSENSORY BEHAVIOR |
6 |
12 |
0.0006458 |
0.003818 |
788 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
12 |
41 |
0.0006532 |
0.003853 |
789 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
48 |
289 |
0.0006533 |
0.003853 |
790 |
DEVELOPMENTAL CELL GROWTH |
18 |
77 |
0.0007108 |
0.004186 |
791 |
POSITIVE REGULATION OF GLIOGENESIS |
13 |
47 |
0.0007168 |
0.004217 |
792 |
REGULATION OF IMMUNE RESPONSE |
118 |
858 |
0.0007383 |
0.004338 |
793 |
REGULATION OF GLIOGENESIS |
20 |
90 |
0.0007393 |
0.004338 |
794 |
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
14 |
53 |
0.0007523 |
0.004408 |
795 |
CHONDROCYTE DEVELOPMENT |
8 |
21 |
0.0007612 |
0.004422 |
796 |
DECIDUALIZATION |
8 |
21 |
0.0007612 |
0.004422 |
797 |
CELL AGGREGATION |
8 |
21 |
0.0007612 |
0.004422 |
798 |
REGULATION OF CHEMOKINE PRODUCTION |
16 |
65 |
0.0007589 |
0.004422 |
799 |
POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL |
8 |
21 |
0.0007612 |
0.004422 |
800 |
REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS |
8 |
21 |
0.0007612 |
0.004422 |
801 |
CARTILAGE CONDENSATION |
8 |
21 |
0.0007612 |
0.004422 |
802 |
MATERNAL PLACENTA DEVELOPMENT |
10 |
31 |
0.0007869 |
0.004565 |
803 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
97 |
684 |
0.0007884 |
0.004569 |
804 |
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE |
19 |
84 |
0.0007895 |
0.004569 |
805 |
NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT |
9 |
26 |
0.0008071 |
0.004659 |
806 |
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
9 |
26 |
0.0008071 |
0.004659 |
807 |
CARBOHYDRATE DERIVATIVE METABOLIC PROCESS |
140 |
1047 |
0.0008099 |
0.00467 |
808 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
12 |
42 |
0.0008294 |
0.004777 |
809 |
REGULATION OF INTERLEUKIN 6 PRODUCTION |
22 |
104 |
0.0008383 |
0.004822 |
810 |
NEGATIVE REGULATION OF CELL CYCLE |
66 |
433 |
0.0008422 |
0.004838 |
811 |
POSITIVE REGULATION OF WOUND HEALING |
13 |
48 |
0.0008912 |
0.005113 |
812 |
ACTIN FILAMENT ORGANIZATION |
32 |
174 |
0.0008966 |
0.005138 |
813 |
MYELOID LEUKOCYTE ACTIVATION |
21 |
98 |
0.0009134 |
0.005228 |
814 |
POSITIVE REGULATION OF CALCIUM ION IMPORT |
14 |
54 |
0.0009202 |
0.00526 |
815 |
REGULATION OF DOPAMINE METABOLIC PROCESS |
7 |
17 |
0.0009531 |
0.005317 |
816 |
REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS |
7 |
17 |
0.0009531 |
0.005317 |
817 |
CORONARY VASCULATURE DEVELOPMENT |
11 |
37 |
0.0009415 |
0.005317 |
818 |
NEGATIVE REGULATION OF PLATELET ACTIVATION |
7 |
17 |
0.0009531 |
0.005317 |
819 |
REGULATION OF NOREPINEPHRINE SECRETION |
7 |
17 |
0.0009531 |
0.005317 |
820 |
REGULATION OF RECEPTOR BINDING |
7 |
17 |
0.0009531 |
0.005317 |
821 |
CYCLIC NUCLEOTIDE CATABOLIC PROCESS |
7 |
17 |
0.0009531 |
0.005317 |
822 |
REGULATION OF PLATELET AGGREGATION |
7 |
17 |
0.0009531 |
0.005317 |
823 |
REGULATION OF PROTEIN KINASE A SIGNALING |
7 |
17 |
0.0009531 |
0.005317 |
824 |
REGULATION OF MUSCLE HYPERTROPHY |
11 |
37 |
0.0009415 |
0.005317 |
825 |
REGULATION OF CALCINEURIN NFAT SIGNALING CASCADE |
7 |
17 |
0.0009531 |
0.005317 |
826 |
NEGATIVE REGULATION OF ANOIKIS |
7 |
17 |
0.0009531 |
0.005317 |
827 |
MAMMARY GLAND ALVEOLUS DEVELOPMENT |
7 |
17 |
0.0009531 |
0.005317 |
828 |
MAMMARY GLAND LOBULE DEVELOPMENT |
7 |
17 |
0.0009531 |
0.005317 |
829 |
MATURE B CELL DIFFERENTIATION |
7 |
17 |
0.0009531 |
0.005317 |
830 |
REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS |
7 |
17 |
0.0009531 |
0.005317 |
831 |
IMPORT INTO CELL |
11 |
37 |
0.0009415 |
0.005317 |
832 |
NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
7 |
17 |
0.0009531 |
0.005317 |
833 |
REGULATION OF CATECHOLAMINE METABOLIC PROCESS |
7 |
17 |
0.0009531 |
0.005317 |
834 |
ACTIVATION OF PROTEIN KINASE A ACTIVITY |
7 |
17 |
0.0009531 |
0.005317 |
835 |
REGULATION OF SYNAPSE ASSEMBLY |
18 |
79 |
0.0009799 |
0.00546 |
836 |
INNER EAR MORPHOGENESIS |
20 |
92 |
0.0009905 |
0.005513 |
837 |
REGENERATION |
30 |
161 |
0.001026 |
0.005705 |
838 |
CELLULAR RESPONSE TO KETONE |
17 |
73 |
0.001034 |
0.005743 |
839 |
CELL CYCLE ARREST |
29 |
154 |
0.001039 |
0.005745 |
840 |
POSITIVE REGULATION OF VASODILATION |
10 |
32 |
0.00104 |
0.005745 |
841 |
BLOOD VESSEL REMODELING |
10 |
32 |
0.00104 |
0.005745 |
842 |
NEGATIVE REGULATION OF T CELL DIFFERENTIATION |
10 |
32 |
0.00104 |
0.005745 |
843 |
CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS |
12 |
43 |
0.001044 |
0.00576 |
844 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
59 |
381 |
0.001049 |
0.005785 |
845 |
CELLULAR RESPONSE TO DRUG |
16 |
67 |
0.001079 |
0.005942 |
846 |
POSITIVE REGULATION OF MUSCLE HYPERTROPHY |
8 |
22 |
0.001089 |
0.005959 |
847 |
ACTIVIN RECEPTOR SIGNALING PATHWAY |
8 |
22 |
0.001089 |
0.005959 |
848 |
REGULATION OF INTERLEUKIN 17 PRODUCTION |
8 |
22 |
0.001089 |
0.005959 |
849 |
POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY |
8 |
22 |
0.001089 |
0.005959 |
850 |
POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT |
8 |
22 |
0.001089 |
0.005959 |
851 |
REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION |
9 |
27 |
0.001101 |
0.005974 |
852 |
HIPPO SIGNALING |
9 |
27 |
0.001101 |
0.005974 |
853 |
BEHAVIORAL RESPONSE TO PAIN |
6 |
13 |
0.001095 |
0.005974 |
854 |
CARDIOBLAST DIFFERENTIATION |
6 |
13 |
0.001095 |
0.005974 |
855 |
POSITIVE REGULATION OF CHEMOKINE PRODUCTION |
13 |
49 |
0.0011 |
0.005974 |
856 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
9 |
27 |
0.001101 |
0.005974 |
857 |
POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION |
9 |
27 |
0.001101 |
0.005974 |
858 |
TRANSMEMBRANE TRANSPORT |
145 |
1098 |
0.001102 |
0.005974 |
859 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
14 |
55 |
0.001119 |
0.00606 |
860 |
POSITIVE REGULATION OF INFLAMMATORY RESPONSE |
23 |
113 |
0.001128 |
0.006105 |
861 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
69 |
462 |
0.001133 |
0.00612 |
862 |
RESPONSE TO NUTRIENT |
34 |
191 |
0.001141 |
0.00616 |
863 |
REGULATION OF DEFENSE RESPONSE |
105 |
759 |
0.001159 |
0.00625 |
864 |
NEGATIVE REGULATION OF ION TRANSPORT |
25 |
127 |
0.001167 |
0.006285 |
865 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
33 |
184 |
0.001174 |
0.006315 |
866 |
RESPONSE TO BACTERIUM |
77 |
528 |
0.001209 |
0.006495 |
867 |
NEGATIVE REGULATION OF HORMONE SECRETION |
17 |
74 |
0.001215 |
0.006523 |
868 |
MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
19 |
87 |
0.001237 |
0.006583 |
869 |
ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
19 |
87 |
0.001237 |
0.006583 |
870 |
VIRAL ENTRY INTO HOST CELL |
19 |
87 |
0.001237 |
0.006583 |
871 |
ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
19 |
87 |
0.001237 |
0.006583 |
872 |
MOVEMENT IN HOST ENVIRONMENT |
19 |
87 |
0.001237 |
0.006583 |
873 |
ENTRY INTO HOST |
19 |
87 |
0.001237 |
0.006583 |
874 |
ENTRY INTO HOST CELL |
19 |
87 |
0.001237 |
0.006583 |
875 |
POSITIVE REGULATION OF HEMOPOIESIS |
30 |
163 |
0.001259 |
0.006694 |
876 |
POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION |
16 |
68 |
0.001278 |
0.006787 |
877 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
36 |
207 |
0.00128 |
0.006792 |
878 |
SYNAPTIC SIGNALING |
64 |
424 |
0.001284 |
0.006803 |
879 |
REGULATION OF PROTEIN KINASE B SIGNALING |
24 |
121 |
0.001299 |
0.006878 |
880 |
NEGATIVE REGULATION OF HEMOPOIESIS |
25 |
128 |
0.001311 |
0.00693 |
881 |
CARDIAC VENTRICLE MORPHOGENESIS |
15 |
62 |
0.001326 |
0.007001 |
882 |
PHENOL CONTAINING COMPOUND METABOLIC PROCESS |
18 |
81 |
0.001331 |
0.007008 |
883 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
18 |
81 |
0.001331 |
0.007008 |
884 |
POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS |
18 |
81 |
0.001331 |
0.007008 |
885 |
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
13 |
50 |
0.001347 |
0.007069 |
886 |
STAT CASCADE |
13 |
50 |
0.001347 |
0.007069 |
887 |
JAK STAT CASCADE |
13 |
50 |
0.001347 |
0.007069 |
888 |
NEURON RECOGNITION |
10 |
33 |
0.001355 |
0.007083 |
889 |
POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS |
10 |
33 |
0.001355 |
0.007083 |
890 |
OUTFLOW TRACT MORPHOGENESIS |
14 |
56 |
0.001352 |
0.007083 |
891 |
REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
21 |
101 |
0.00137 |
0.007156 |
892 |
CALCIUM ION TRANSPORT |
38 |
223 |
0.001406 |
0.007335 |
893 |
REGULATION OF EXOCYTOSIS |
33 |
186 |
0.001416 |
0.007379 |
894 |
REGULATION OF HETEROTYPIC CELL CELL ADHESION |
7 |
18 |
0.001421 |
0.007389 |
895 |
CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS |
7 |
18 |
0.001421 |
0.007389 |
896 |
CELLULAR RESPONSE TO INTERLEUKIN 1 |
19 |
88 |
0.001427 |
0.007411 |
897 |
RESPONSE TO ETHANOL |
26 |
136 |
0.001467 |
0.007605 |
898 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
25 |
129 |
0.001469 |
0.007605 |
899 |
REGULATION OF CAMP METABOLIC PROCESS |
25 |
129 |
0.001469 |
0.007605 |
900 |
RIBONUCLEOTIDE CATABOLIC PROCESS |
9 |
28 |
0.001475 |
0.007607 |
901 |
MUSCLE HYPERTROPHY |
9 |
28 |
0.001475 |
0.007607 |
902 |
REGULATION OF FATTY ACID OXIDATION |
9 |
28 |
0.001475 |
0.007607 |
903 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
31 |
172 |
0.001499 |
0.007715 |
904 |
G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER |
31 |
172 |
0.001499 |
0.007715 |
905 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
34 |
194 |
0.001502 |
0.007721 |
906 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
11 |
39 |
0.001521 |
0.007742 |
907 |
REGULATION OF AXON GUIDANCE |
11 |
39 |
0.001521 |
0.007742 |
908 |
POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
11 |
39 |
0.001521 |
0.007742 |
909 |
REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING |
8 |
23 |
0.001519 |
0.007742 |
910 |
TRABECULA MORPHOGENESIS |
11 |
39 |
0.001521 |
0.007742 |
911 |
REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN |
11 |
39 |
0.001521 |
0.007742 |
912 |
TRABECULA FORMATION |
8 |
23 |
0.001519 |
0.007742 |
913 |
REGULATION OF RESPIRATORY GASEOUS EXCHANGE |
8 |
23 |
0.001519 |
0.007742 |
914 |
NEUROTROPHIN SIGNALING PATHWAY |
8 |
23 |
0.001519 |
0.007742 |
915 |
REGULATION OF DEPHOSPHORYLATION |
29 |
158 |
0.001569 |
0.007981 |
916 |
GLYCEROLIPID METABOLIC PROCESS |
55 |
356 |
0.001603 |
0.008144 |
917 |
EXOCRINE SYSTEM DEVELOPMENT |
12 |
45 |
0.001611 |
0.008154 |
918 |
SMOOTH MUSCLE CONTRACTION |
12 |
45 |
0.001611 |
0.008154 |
919 |
HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
12 |
45 |
0.001611 |
0.008154 |
920 |
REGULATION OF JAK STAT CASCADE |
27 |
144 |
0.001621 |
0.008189 |
921 |
REGULATION OF STAT CASCADE |
27 |
144 |
0.001621 |
0.008189 |
922 |
FEMALE SEX DIFFERENTIATION |
23 |
116 |
0.001628 |
0.008218 |
923 |
NEGATIVE REGULATION OF CHEMOTAXIS |
13 |
51 |
0.00164 |
0.008249 |
924 |
NEGATIVE REGULATION OF CALCIUM ION TRANSPORT |
13 |
51 |
0.00164 |
0.008249 |
925 |
POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION |
13 |
51 |
0.00164 |
0.008249 |
926 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
43 |
263 |
0.001659 |
0.008338 |
927 |
POSITIVE REGULATION OF CYTOKINE SECRETION |
20 |
96 |
0.001717 |
0.008621 |
928 |
REGULATION OF CYTOSKELETON ORGANIZATION |
73 |
502 |
0.001722 |
0.008632 |
929 |
SULFUR COMPOUND BIOSYNTHETIC PROCESS |
35 |
203 |
0.001727 |
0.00865 |
930 |
RESPONSE TO RADIATION |
62 |
413 |
0.001729 |
0.008653 |
931 |
POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
6 |
14 |
0.001749 |
0.008656 |
932 |
POSITIVE REGULATION OF VACUOLAR TRANSPORT |
6 |
14 |
0.001749 |
0.008656 |
933 |
POSITIVE REGULATION OF SODIUM ION TRANSPORT |
10 |
34 |
0.001744 |
0.008656 |
934 |
EPITHELIAL CELL CELL ADHESION |
6 |
14 |
0.001749 |
0.008656 |
935 |
RESPONSE TO PROSTAGLANDIN |
10 |
34 |
0.001744 |
0.008656 |
936 |
POSITIVE REGULATION OF P38MAPK CASCADE |
6 |
14 |
0.001749 |
0.008656 |
937 |
REGULATION OF GLOMERULUS DEVELOPMENT |
6 |
14 |
0.001749 |
0.008656 |
938 |
CAMP CATABOLIC PROCESS |
6 |
14 |
0.001749 |
0.008656 |
939 |
CELLULAR RESPONSE TO VITAMIN D |
6 |
14 |
0.001749 |
0.008656 |
940 |
POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY |
6 |
14 |
0.001749 |
0.008656 |
941 |
PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
18 |
83 |
0.001785 |
0.008806 |
942 |
RESPONSE TO FATTY ACID |
18 |
83 |
0.001785 |
0.008806 |
943 |
REGULATION OF POTASSIUM ION TRANSPORT |
18 |
83 |
0.001785 |
0.008806 |
944 |
LIPID LOCALIZATION |
43 |
264 |
0.001788 |
0.008815 |
945 |
SPHINGOLIPID METABOLIC PROCESS |
26 |
138 |
0.001822 |
0.008973 |
946 |
CELLULAR RESPONSE TO STARVATION |
23 |
117 |
0.001833 |
0.009014 |
947 |
REGIONALIZATION |
49 |
311 |
0.001851 |
0.009095 |
948 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
15 |
64 |
0.001865 |
0.009156 |
949 |
CALCIUM MEDIATED SIGNALING |
19 |
90 |
0.001883 |
0.009234 |
950 |
TYROSINE PHOSPHORYLATION OF STAT PROTEIN |
5 |
10 |
0.001897 |
0.00929 |
951 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
11 |
40 |
0.001904 |
0.009308 |
952 |
NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
11 |
40 |
0.001904 |
0.009308 |
953 |
REGULATION OF SODIUM ION TRANSPORT |
17 |
77 |
0.001928 |
0.009405 |
954 |
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
17 |
77 |
0.001928 |
0.009405 |
955 |
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION |
9 |
29 |
0.001944 |
0.009443 |
956 |
REGULATION OF VACUOLAR TRANSPORT |
9 |
29 |
0.001944 |
0.009443 |
957 |
RESPONSE TO PAIN |
9 |
29 |
0.001944 |
0.009443 |
958 |
MUSCLE ADAPTATION |
9 |
29 |
0.001944 |
0.009443 |
959 |
REGULATION OF INTERLEUKIN 10 PRODUCTION |
12 |
46 |
0.001977 |
0.009543 |
960 |
PEPTIDYL THREONINE MODIFICATION |
12 |
46 |
0.001977 |
0.009543 |
961 |
CYCLIC NUCLEOTIDE MEDIATED SIGNALING |
12 |
46 |
0.001977 |
0.009543 |
962 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND |
12 |
46 |
0.001977 |
0.009543 |
963 |
REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
12 |
46 |
0.001977 |
0.009543 |
964 |
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS |
12 |
46 |
0.001977 |
0.009543 |
965 |
REGULATION OF LIPID CATABOLIC PROCESS |
13 |
52 |
0.001983 |
0.009561 |
966 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
27 |
146 |
0.001995 |
0.00961 |
967 |
REGULATION OF NEUROTRANSMITTER LEVELS |
33 |
190 |
0.002033 |
0.009781 |
968 |
APOPTOTIC SIGNALING PATHWAY |
46 |
289 |
0.002038 |
0.009799 |
969 |
FIBRIL ORGANIZATION |
7 |
19 |
0.002051 |
0.009828 |
970 |
NEGATIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
7 |
19 |
0.002051 |
0.009828 |
971 |
NEGATIVE REGULATION OF ATP METABOLIC PROCESS |
7 |
19 |
0.002051 |
0.009828 |
972 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
80 |
563 |
0.002057 |
0.009845 |
973 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
24 |
125 |
0.002059 |
0.009848 |
974 |
ADHERENS JUNCTION ORGANIZATION |
16 |
71 |
0.002068 |
0.00988 |
975 |
NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION |
8 |
24 |
0.002074 |
0.009889 |
976 |
REGULATION OF ANOIKIS |
8 |
24 |
0.002074 |
0.009889 |